Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue. Popowycz, F.; Fournet, G.; Schneider, C.; Bettayeb, K.; Ferandin, Y.; Lamigeon, C.; Tirado, O. M.; Mateo-Lozano, S.; Notario, V.; Colas, P.; Bernard, P.; Meijer, L.; Joseph, B.J. Med. Chem. 2009, 52, 655-663.
Unexpected C2-arylation of 1-(pyridin-2-yl)indole-3-carboxaldehyde mediated by copper. Sagnes, C.; Fournet, G.; Joseph, B.Synlett2009, 433-436.
Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives. Popowycz, F.; Schneider, C.; DeBonis, S.; Skoufias, D. A.; Kozielski, F.; Galmarini, C. M.; Joseph, B.Bioorg. Med. Chem. 2009, 17, 3471-3478.
Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration. Hiltbrand, E.; Fournet, G.; Giliberto, J.-P.; Paret, M.-J.; Chantepie, J.; Morel, D.; Gore, J.; Reichert, U.; Mehier, H.; Rochedix, M.-E.; Quash, G. Curr. Med. Chem. 2009, 16, 1184-1191.
New Insights in the Homopiperazine-based 5-HT1A/5-HT7R ligands: Synthesis and biological evaluation. Badarau, E.; Putey, A.; Suzenet, F.; Joseph, B.; Bojarski, A. J.; Fînaru, A.-L.; Guillaumet, G. J. Enz. Inhib. Med. Chem. 2009, 25, 301-305.
Indolobenzazepin-7-ones and 6-, 8- and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure-activity relationships. Putey, A.; Popowycz, F.; Do, Q.-T.; Bernard, P.; Talapatra, S. K.; Kozielski, F.; Galmarini, C. M.; Joseph,J. Med. Chem. 2009,52, 5916-5925.
Methionine-derived metabolites in apoptosis: therapeutic opportunities for inhibitors of their metabolism in chemoresistant cancer cells. Quash, G.; Fournet, G.
Chemoselective functionalization of α-carbolines at the C-2, C-3, C-4 and C-6 positions using Suzuki-Miyaura reactions. Schneider, C.; Gueyrard, D.; Joseph, B.; Goekjian, P. G. Tetrahedron2009, 65, 5427-5437.
A simple access to metallic or onium bistrifluoromethanesulfonimide salts. Arvai, R.; Toulgoat, F.; Langlois, B. R.; Sanchez, J-.Y.; Médebielle, M. Tetrahedron 2009, 65, 5361-5368.
An efficient and selective synthetic method for fluorine-containing benzo[h]quinolines and 1H-benzo[h]quinolin-2-ones from N-propargyl-2,4-bis(trifluoroacetyl)-1-naphthylamine. Okada,
Fluorine-containing 1,10-phenanthrolines synthesis: an original and efficient approach by the pyridine-ring formation reaction of N-propargyl-5,7-bis(trifluoroacetyl)-8-quinolylamine with various nucleophiles. Shibata, D.; Okada, E.; Molette, J.; Médebielle, M.Tetrahedron 2009, 65, 6189-6195
A facile synthetic method for fluorine-containing 1,7-phenanthrolines: pyridine-ring formation reaction of N-propargyl-6,8-bis(trifluoroacetyl)-5-quinolylamine with various nucleophiles. Shibata, D.; Okada, E.; Hinoshita, M.; Médebielle, M.Synthesis2009, 3039-3046.
Single end-to-end azidocopper(II) chain based on an electroactive ligand: a structural, electrochemical, magnetic and ab initio study. Pilet, G.; Médebielle, M.; Tommasino, J.-B.; Chastanet, G.; Le Guennic, B.; Train, C. Eur. J. Inorg. Chem.2009, 4718-4726.
MicroRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection, Carpio, L.; Klase, Z.; Coley, W.; Guendel, I.; Choi, S.; Van Duyne, R.; Narayanan, A.; Khen-Hall, K.; Galons, H.; Oumata, N.; Joseph, B.; Meijer, L.; Kashanchi, F. J. RNAi Gene Silencing 2010, 6, 386-400.
Synthesis of 2-, 3- and 4-substituted pyrido[2,3-b]indoles by C-N, C-O and C-C(sp) bond formation. Schneider, Goyard, D.; Gueyrard, D.; Joseph, B.; Goekjian, P. G.Eur. J. Org. Chem. 2010, 6665-6677.
A concise synthesis of fluorine-containing benzo[h]quinolines and benzo[h]quinolones by selective pyridine and pyridinone rings formation reactions of N-propargyl-2,4-bis(trifluoroacetyl)-1-naphthylamine with various active methylene compounds. Okada, E.; Shibata, D.; Tsukushi, N.; Dohura, M.; Ota, N.; Adachi, S.; Médebielle, M.Heterocycles2010, 81, 357-370.
Direct aldol – reduction process using difluoromethyl ketones and aryl aldehydes in the presence of potassium tert-Butoxide: one-pot efficient stereoselective synthesis of symmetrical and unsymmetrical anti-2,2-difluoropropane-1,3-diols. Xu, W.; Médebielle, M.; Bellance, M.-H.; Dolbier, W. R., Jr. Adv. 2010, 352, 2787-2790.
A facile synthesis of fluorine-containing 1,7-phenanthrolines by the cyclization of N-propargyl-6,8-bis(trifluoroacetyl)quinolin-5-amine with various active methylene compounds. Shibata, D.; Sakai, A.; Hatakenaka, M.; Saikawa, S.; Kamitori, Y.; Médebielle, M.; Okada E. Heterocycles2010, 82, 803-812.
Structure-activity relationship and multidrug resistance of newS-trityl-L-cysteine derivatives as inhibitors of Eg5.Kaan,H. Y. K.; Weiss, J.; Menger, D.; Ulaganathan, V.; Tkocz, K.; Laggner, C.; Popowycz, F.; Joseph, B.; Kozielski, F.J. Med. Chem. 2011, 54, 1576-1586.
Unexpected matrix interactions in liquid secondary ion mass spectrometry of two pyranosylmercaptans. Gardrat, C.; Joseph, B.; Vitry, C.; Castellan, A.; Rollin, P. Rapid Commun. Mass Spectrom. 2011, 25, 1399-1406.
Chopin, N.; Decamps, S.; Gouger, A.; Médebielle, M.; Picot, S.; Bienvenu, A.-L.; Pilet, G., J. Fluorine. 2011, 132, 850-857.
Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Boyer, J.; Arnoult, E.; Médebielle, M.; Guillemont, J.; Unge, J.; Jochmans, D. J. Med. Chem.2011, 54, 7974-7985.
Syntheses of a wide family of new aryl based perflurosulfonimide lithium salts. Electrochemical performances of the related polymer electrolytes. Paillard, E.; Toulgoat, F.; Arvai, R.; Iojoiu, L.; Cointeaux, C.; Médebielle, M.; Alloin, F.; Langlois B.; Sanchez. J.-Y. J. Fluorine. Chem.2011, 132, 1213-1218.
Targeting Low Molecular Weight Cyclin E (LMW-E) in Breast Cancer. Nanos-Webb, A.; Jabour, N. A.; Multani, A. S.; Wingate, H.; Oumata, N.; Galons, H.; Joseph, B.; Meijer, L.; Hunt, K. K.; Keyomarsi, K. Breast Cancer Res. Treat. 2012, 132, 575-588.
Inhibition of Hepatitis C Virus NS5B Polymerase by S-Trityl-L-cysteine Derivatives. Nichols, D. B.; Fournet, G.; Gurukumar, K. R.; Basu, A.; Lee, J.-C.; Sakamoto, N.; Kozielski, F.; Musmuca, I.; Joseph, B.; Ragno, R.; Kaushik-Basu, N. Eur. J. Med. Chem. 2012, 49, 191-199.
Use of ATP analogs to inhibit HIV-1 transcription, Narayanan, A.; Sampey, G.; Van Duyne, R.; Guendel, I.; Kehn-Hall, K.; Roman, J.; Currer, R.; Galons, H.; Oumata, N.; Joseph, B.; Meijer, L.; Caput, M.; Nekhai, S.; Kashanchi, F. Virology2012, 432, 219-231.
A facile and convenient method for the synthesis of 6,8-bis(trifluoroacetyl)quinoline-5-ones. Shibata, D.; Médebielle, M.; Hatakenaka, M.; Okada E. Heterocycles2012, 84, 1277-1284.
Polymer electrolytes based on new aryl-containing lithium perfluorosulfonates. Paillard, E.; Toulgoat, F.; Iojoiu, C.; Alloin, F.; Guindet, J.; Médebielle, M.; Langlois B.; Sanchez, J.-Y. 2012, 134, 72-76.
Bidentate and tetradentate b-aminovinyl trifluoromethylated ketones and their copper(II) complexes: synthesis, characterization and redox chemistry. Chopin, N.; Médebielle, M.; Pilet, G. 2012, 1093-1103.
Copper(II) cubane complexes built from electro- and photo-sensitive b-aminovinyl trifluoromethyl ketone ligands. Chopin, N.; Chastanet, G.; Le Guennic, B.; Médebielle, M.; Pilet, G. Eur. J. Inorg. Chem. 2012, 5058-5070.
Recent advances in the synthesis and properties of 4-, 5-, 6-, 7-azaindoles. Merour, J.-Y.; Routier, S.; Suzenet, F.; Joseph,Tetrahedron 2013, 69, 4767-4834.
α,β-acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosis. Fournet, G.; Martin, G.; Quash, G. Curr. Med. Chem.2013, 20, 527-533.
Incorporation of a 3-(2,2,2-trifluoroethyl)-g-hydroxy-g-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities. Cornut, D.; Lemoine, H.; Kanishchev, O.; Okada, E.; Albrieux, F.; Beavogui, A. H.; Bienvenu, A.-L.; Picot, S.; Bouillon, J.-P.; Médebielle,M.J. Med. Chem.2013, 56, 73-83.
Catalytic hydrotrifluoromethylation of unactivated alkenes. Mizuta, S.; Verhoog, S.; Engle, K. M.; Khotavivattana, T.; O’Duill, M.; Wheelhouse, K.; Rassias, G.; Médebielle, M.; Gouverneur, V. J. Am. Chem. Soc.2013, 135, 2505-2508.
Trifluoromethylation of allylsilanes under photoredox catalysis. Mizuta, S.; Engle, K. M.; Verhoog, S.; Lopez, O. G.; O’Duill, M.; Médebielle, M.; Wheelhouse, K.; Rassias, G.; Thompson, A. L.; Gouverneur, V. Org. Lett. 2013, 15, 1250-1253.
Regioselective bromination of tetronic acid-derived g-lactones and metal-catalyzed post-functionalization. An efficient access to new g-ylidenetetronate derivatives. Iikawa, S.; Chopin, N.; Pilet, G.; Bouillon, J.-P.; Médebielle, M.Tetrahedron Lett. 2013, 54, 4577-4581.
8-Aminoquinoline and 2-aminopyridine trifluoromethyl-derived enaminone ligands and their Co(II), Ni(II) and Zn(II) metal complexes: structural arrangements due to F-H interactions. Chopin, N.; Pilet, G.; Médebielle, M. J. Fluorine. Chem.2013, 155, 89-96.
New route to the 5-((arylthio- and heteroarylthio)methylene)-3-(2,2,2-trifluoroethyl)-furan-2(5H)-ones - Key intermediates in the synthesis of 4-aminoquinoline -lactams as potent antimalarial compounds. Kanishchev, O.; Lavoignat, A.; Picot, S.; Médebielle, M.; Bouillon, J.-P. Bioorg. Med. Chem. Lett.2013, 23, 6167-6171.
New N-arylindoles based serotonin 5-HT7 ligands. Synthesis and binding evaluation studies. Sagnes, C.; Fournet, G.; Satala, G.; Bojarski, A.; Joseph, B. Eur. J. Med. 2014, 75, 159-168.
Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors. Putey, A.; Fournet, G.; Lozach, O.; Perrin, L.; Meijer, L.; Joseph, B. Eur. J. Med. Chem. 2014, 83, 617-629.
Trifluoromethyl-derived enaminones and their difluoroboron complexes: synthesis, crystal structure and electrochemistry properties. Chopin, N.; Pilet, G.; Morita, Y.; Médebielle, M.J. Fluorine. Chem.2014, 167, 211-225.
Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Jarry, M.; Lecointre, C.; Malleval, C.; Desrues, L.; Schouft, M.-T.; Lejoncour, V.; Liger, F.; Lyvinec, G.; Joseph, B.; Loaëc, N.; Meijer, L.; Honnorat, J.; Gandolfo, P.; Castel, H. Neuro Oncol.2014, 16, 1484-1498.
Quenching of fluorescence in bodipy-derived trifluoromethyl enaminone ligands upon coordination to copper(II). Chopin, N.; Médebielle, M.; Maury, O.; Novitchi, G.; Pilet, G. Eur. J. Inorg. Chem.2014, 6185-6195.
Biologie
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot, S.; Olliaro, P.; de Monbrison, F.; Bienvenu, A. L.; Price, R.; Ringwald, P. Malaria J.2009, 8, 89.
Epoietin beta-Quinine drug combination in children with cerebral malaria in Mali. Picot, S.; Bienvenu, A. L.; Konate, S.; Sissoko, S.; Barry, A.; Diarra, E.; Bamba, K.; Djimde, A.; Doumbo, O. K. Malaria J.2009, 8, 169.
Malaria. Picot, S.Rev. Prat.2009, 59, 1135-1141.
Analysis of diluted vitreous samples from vitrectomy is useful in eyes with severe acute postoperative endophthalmitis. Chiquet, C.; Maurin, M.; Thuret, G.; Benito, Y.; Cornut, P. L.; Creuzot-Garcher, C.; Rouberol, F.; Pechinot, A.; Lina, G.; Romanet, J. P.; Bron, A.; Vandenesch, F. and the French Institutional Endophthalmitis Group (Picot, S.) Ophthalmology 2009, 116, 2437-2441.
Plasmodium vivax infection: not so benign. Picot, S.; Bienvenu, A. L.Med. Sci. (Paris) 2009, 25, 622-626.
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana. Barnadas, C.; Musset, L.; Legrand, E.; Tichit, M.; Briolant, S.; Fusai, T.; Rogier, C.; Bouchier, C.; Picot, S.; Ménard, D. Am. J. Trop. Med. Hyg.2009, 81, 19-22.
Can erythropoietin be used to prevent brain damage in cerebral malaria? Casals-Pascual, C.; Idro, R.; Picot, S.; Roberts, D. J.; Newton, C. R. Trends Parasitol. 2009, 25, 30-36.
5th Multilateral Initiative on Malaria meeting. Une réunion mondiale pour de nouveaux espoirs? Bienvenu, A. L. Parasite 2010, 17, 166.
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. Ader, F.; Bienvenu, A. L.; Rammaert, B.; Nseir, X. Int. J. Chron. Obstruct. Pulmon. Dis.2009, 4, 279-287.
Acute liver failure may lead to lethal pulmonary aspergillosis. Bienvenu, A. L.; Walter, T.; Boulez, F.; Faure, A. C.; Ber, C. E.; Allaouchiche, B.; Dumortier, J.; Picot, S. J. Clin. 2010, 44, 593-594.
International, Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole. Lortholary, O.; Obenga, G.; Biswas, P.; Caillot, D.; Chachaty, E.; Bienvenu, A. L.; Cornet, M.; Greene, J.; Herbrecht, R.; Lacroix, C.; Grenouillet, F.; Raad, I.; Sitbon, K.; Troke, P.; 2010, 54, 4446-4450.
Apoptosis induced by parasitic diseases. Bienvenu, A. L.; Gonzalez-Rey, E.; Picot, S.Parasit Vectors2010, 3, 106.
Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. Bruneel, F.; Tubach, F.; Corne, P.; Megarbane, B.; Mira, J. P.; Peytel, E.; Camus, C.; Schortgen, F.; Azoulay, E.; Cohen, Y.; Georges, H.; Meybeck, A.; Hyvernat, H.; Trouillet, J. L.; Frenoy, E.; Nicolet, L.; Roy, C.; Durand, R.; Le Bras, J.; Wolff, M.and collaborators of the SIMA Study Group (Picot, S.)PLoS One 2010, 5, e13236.
Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Beavogui, A. H.; Djimde, A. A.; Gregson, A.; Toure, A. M.; Dao, A.; Coulibaly, B.; Ouologuem, D.; Fofana, B.; Sacko, A.; Tekete, M.; Kone, A.; Niare, O.; Wele, M.; Plowe, C. V.; Picot, S.; Doumbo, O. K. Int. J. Parasitol. 2010, 40, 1213-1220.
Are protozoan metacaspases potential parasite killers? Picot, S.; Zalila, H.; Meslin, B.; Fasel, N.; Bienvenu, A. L. Parasit Vectors 2011, 4, 26.
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Michallet, M.; Morisset, S.; Kraghel, S.; Nicolini, F. E.; Thomas, X.; Sobh, M.; Bienvenu, A. L.;Picot, S.; Nicolle, M. C.; Vanhems, P. Med. Mycol.2011, 49, 681-687.
Primary cutaneous cryptococcosis in a liver transplant recipient. Ferry, T.; Moos, D.; Radenne, S.; Bienvenu, A. L.; Kanitakis, J. BMJ Case Reports, doi:10.1136/bcr.02.2011.3814.
Invasive aspergillosis in patients with hematological malignancy: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Nicolle, M. C.; Bénet, T.; Thiebaut, A.; Bienvenu, A. L.; Voirin, N.; Duclos, A.; Sobh, M.; Cannas, G.; Thomas, X.; Nicolini, F.-E.; De Monbrison, F.; Piens, M.-A.; Picot, S.; Michallet, M.; Vanhems, P. Haematologica2011, 96, 1685-1691.
Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Peigne, V.; Dromer, F.; Elie, C.; Lidove, O.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Am. J. Trop. Med. Hyg.2011, 85, 934-941.
Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death. Meslin, B.; Beavogui, A. H.; Fasel, N.; Picot, S.PLoS One 2011, 6, e23867
Update on genetic markers of quinine resistance in Plasmodium falciparum. Okombo, J.; Ohuma, E.; Picot, S.; Nzila, A. Mol. Biochem. Parasitol. 2011, 177, 77-82.
Advantages and limits of real-time PCR assay and PCR-restriction fragment length polymorphism for the identification of cutaneous Leishmania species in Tunisia. Ben Abda, I.; de Monbrison, F.; Bousslimi, N.; Aoun, K.; Bouratbine, A.; Picot S. Trans. R. Soc. Trop. Med. Hyg.2011, 105, 17-22.
Candida spp. with acquired echinocandin resistance, France, 2004-2010. Dannaoui, E.; Desnos-Ollivier, M.; Garcia-Hermoso, D.; Grenouillet, F.; Cassaing, S.; Baixench, M. T.; Bretagne, S.; Dromer, F.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Emerg. Infect. Dis.2012, 18, 86-90.
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Lanternier, F.; Dannaoui, E.; Morizot, G.; Elie, C.; Garcia-Hermoso, D.; Huerre, M.; Bitar, D.; Dromer, F.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Clin. Infect. Dis.2012; 54, S35-43.
Invasive Aspergillosis: An Important Risk Factor on Short and Long-term Survival of AML Patients. Michallet, M.; Bénet, T.; Sobh, M.; Kraghel, S.; El Hamri, M.; Cannas, G.; Nicolini, F. E.; Labussière, H.; Ducastelle, S.; Barraco, F.; Thomas, X.; Chelghoum, Y.; Nicolle, M. C.; Bienvenu, A. L.; Persat, F.; De Monbrison, F.; Picot, S.; Vanhems, P. Eur. J. Clin. Microbiol.2012, 31, 991-997.
Therapeutic Efficacy of Artemether-Lumefantrine treatment for Plasmodium falciparum and Plasmodium vivax infections in a prospective multicentre study in Guyana. Eibach, D.; Ceron, N.; Krishnalall, K.; Carter, K.; Ringwald, P.; Bonnot, G.; Bienvenu, A. L.; Picot, S.Malaria J.2012, 11, 347.
Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic features.Biancheri, D.; Kanitakis, J.; Bienvenu, A. L.; Picot, S.; Morelon, E.; Faure, M.; Euvrard, S. 2012, 22, 651-657.
Droplet Microfluidics Platform for Highly Sensitive and Quantitative Detection of Malaria Causing Plasmodium Parasites Based on Enzyme Activity Measurement. Juul, S.; Nielsen, C.; Labouria, R.; Roy, A.; Tesauro, C.; Jensen, P.; Harmsen, C.; Kristoffersen, E.; Chiu, Y. L.; Frøhlich, R.; Fiorani, P.; Cox, J.; Tordrup, D.; Koch, J.; Bienvenu, A. L.; Desideri, A.; Picot, S.; Petersen, E.; Leong, K.; Ho, Y. P.; Stougaard, M.; Knudsen, B. A. ACS Nano. 2012, 6, 10676-10683.
Phaeohyphomycosis caused by Pyrenochaeta romeroi mimicking a plantar wart in a kidney transplant recipient.Ocampo, M. A.; Kanitakis, J.; Bienvenu, A. L.; Chauvet C.; Euvrard S. Transpl. 2012, 14, E173-E174.
Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia. Sutanto, I.; Suprianto, S.; Widiaty, A.; Rukmiyati, X.; Ruckert, P.; von Bethmann, A.; de Monbrison, F.; Picot, S.; Laihad, F.; Baird, J. K. Acta Med. Indones. 2012, 44, 187-192.
Utility of real-time PCR for the diagnosis of infantile visceral leishmaniasis in Algeria. Mihoubi, I.; de Monbrison, F.; Frahtia, K.; Picot, S.; Gassem, N. Med. Sante Trop. 2012, 22, 61-64.
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Pascual, A.; Parola, P.; Benoit-Vical, F.; Simon, F.; Malvy, D.; Picot, S.; Delaunay, P.; Basset, D.; Maubon, D.; Faugère, B.; Ménard, G.; Bourgeois, N.; Oeuvray, C.; Didillon, E.; Rogier, C.; Pradines, B. Malaria J. 2012, 11, 45.
Relationship between baseline clinical data and microbiologic spectrum in 100 patients with acute postcataract endophthalmitis. Cornut, P. L.; Thuret, G.; Creuzot-Garcher, C.; Maurin, M.; Pechinot, A.; Bron, A.; Gain, P.; Carricajo, A.; Denis, P.; Romanet, J. P.; Vandenesch, F.; Chiquet, C. and the French Institutional Endophthalmis Study Group (Picot, S.) Retina. 2012, 32, 549-557.
The efficacy of voriconazole in 24 ocular Fusarium infections. Troke, P.; Obenga, G.; Gaujoux, T.; Goldschmidt, P.; Bienvenu, A. L.; Cornet, M.; Grenouillet, F.; Pons, D.; Ranque, S.; Sitbon, K.; Chaumeil, C.; Borderie, V.; Lortholary, O. Infection.2013, 41, 15-20.
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Gharbi, M.; Flegg, J. A.; Hubert, V.; Kendjo, E.; Metcalf, J. E.; Bertaux, L.; Guérin, P. J.; Le Bras, J. and the Members of the French National Reference Centre for Imported Malaria Study (Picot, S.)Malaria J. 2013, 12, 35.
Evaluation of the malaria rapid diagnostic test VIKIA malaria Ag Pf/Pan™ in endemic and non-endemic settings. Eibach, D.; Traore, B.; Bouchrik, M.; Coulibaly, B.; Coulibaly, N.; Siby, F.; Bonnot, G.; Bienvenu, A. L.;Picot, S.Malaria J.2013, 12, 188.
A multicentre, randomized, open label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail alone in dermatophytic onychomycosis. Paul, C.; Coustou, D.; Lahfa, M.; Bulai-Livideanu, C.; Doss, N.; Mokthar, I.; Turki, H.; Nouira, R.; Fazaa, B.; Ben Osman, A.; Zourabichvili, O.; Cazeau, C.; Coubetergues, H.; Picot, S.;Bienvenu, A. L.; Voisard, J. J. Dermatology 2013, 227, 157-164.
Molecular diagnosis by real-time PCR of Leishmania isolated from the Phlebotomus vector. Frahtia-Benotmane, K.; Mihoubi, I.; Picot, S.Med. Sante Trop.2013, 23, 230.
Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Parmeland, L.; Gazon, M.; Guerin, C.; Argaud, L.; Lehot, J. J.; Bastien, O.; Allaouchiche, B.; Michallet, M.; Picot, S.; Bienvenu, A. L. . 2013, 51, 33-37.
Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients. Bénet, T.; Voirin, N.; Nicolle, M. C.; Picot, S.; Michallet, M.; Vanhems, P. Med. Mycol. 2013, 51,214-218.
Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Wallon, M.; Garweg, J. G.; Abrahamowicz, M.; Cornu, C.; Vinault, S.; Quantin, C.; Bonithon-Kopp, C.; Picot, S.; Peyron, F.; Binquet, C. Pediatrics 2014, 133, e601-e608.
Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. Parize, P.; Billaud, S.; Bienvenu, A. L.; Bourdy, S.; le Pogam, M. A.; Reix, P.; Picot, S.; Robert, R.; Lortholary, O.; Bouchara, J. P.; Durieu, I. J. Cyst. Fibros.2014, 13, 667-673.
New antimalarial drugs: who cares? Picot, S.; Loiseau, P. M.; Bienvenu, A. L.Curr. Top. Med. Chem.2014, 14, 1637-1642.